Treatment of Vulvovaginitis Caused by Yeast
For uncomplicated vulvovaginal candidiasis, either topical antifungal agents or a single 150-mg oral dose of fluconazole is strongly recommended as first-line treatment. 1
Diagnosis Confirmation
Before initiating treatment, confirm the diagnosis with:
- Clinical symptoms: pruritus, irritation, vaginal soreness, dyspareunia
- Physical signs: vulvar edema, erythema, white curdlike discharge
- Laboratory confirmation: wet-mount preparation with saline and 10% potassium hydroxide (KOH) to demonstrate yeast or hyphae
- Normal vaginal pH (≤4.5)
Treatment Options for Uncomplicated Cases
Topical Antifungal Options:
- Clotrimazole 1% cream 5g intravaginally for 7-14 days 1
- Clotrimazole 100mg vaginal tablet for 7 days 1
- Clotrimazole 500mg vaginal tablet, single application 1
- Miconazole 2% cream 5g intravaginally for 7 days 1
- Miconazole 200mg vaginal suppository, one daily for 3 days 1
- Terconazole 0.4% cream 5g intravaginally for 7 days 1, 2
- Terconazole 0.8% cream 5g intravaginally for 3 days 1
- Butoconazole 2% cream 5g intravaginally for 3 days 1
Oral Option:
- Fluconazole 150mg oral tablet, single dose 1
Treatment for Severe Acute Vulvovaginitis
For severe acute cases:
- Fluconazole 150mg every 72 hours for a total of 2-3 doses 1
Special Considerations for C. glabrata Infections
C. glabrata often shows resistance to azoles 3. Treatment options include:
- Topical intravaginal boric acid, 600mg daily for 14 days (strong recommendation) 1
- Nystatin intravaginal suppositories, 100,000 units daily for 14 days 1
- Topical 17% flucytosine cream alone or with 3% AmB cream daily for 14 days 1
Management of Recurrent Vulvovaginal Candidiasis
For recurring vulvovaginal candidiasis:
- Induction therapy with topical agent or oral fluconazole for 10-14 days
- Followed by maintenance therapy with fluconazole 150mg weekly for 6 months 1
Clinical Pearls and Pitfalls
- Diagnostic pitfall: Symptoms of vulvovaginal candidiasis (pruritus, discharge, soreness) are nonspecific and can be caused by other conditions. Always confirm diagnosis before treatment 1, 4
- Treatment pitfall: Non-albicans Candida species (especially C. glabrata) are more common in recurrent cases (42% vs 20% in initial infections) and often require alternative treatments 3
- Self-treatment caution: Self-medication with OTC preparations should only be advised for women previously diagnosed with VVC who experience recurrence of the same symptoms 1
- Follow-up recommendation: If symptoms persist after 72 hours of appropriate therapy, consider alternative diagnosis 5
Treatment Algorithm
Uncomplicated first episode:
- Either topical azole for 1-7 days OR
- Single dose oral fluconazole 150mg
Severe acute episode:
- Fluconazole 150mg every 72 hours for 2-3 doses
Suspected C. glabrata infection (not responding to azoles):
- Boric acid 600mg intravaginally daily for 14 days
Recurrent vulvovaginal candidiasis:
- Induction: 10-14 days of topical or oral therapy
- Maintenance: Fluconazole 150mg weekly for 6 months
This evidence-based approach to treating vulvovaginal candidiasis focuses on proper diagnosis and targeted therapy based on clinical presentation and causative species, ensuring optimal outcomes for patients with this common condition.